Reducing Sitting Time after Stroke: A Phase II Safety and Feasibility Randomized Controlled Trial Presented in part as a poster to the European Stroke Organization, April 17-19, 2015, Glasgow, United Kingdom; And Stroke 2015 (a combined conference of the Stroke Society of Australasia and Smartstrokes NSW), September 1-5, 2015, Melbourne, VIC, Australia.

Abstract

Objective To test the safety, feasibility, and effectiveness of reducing sitting time in stroke survivors. Design Randomized controlled trial with attention-matched controls and blinded assessments. Setting Community. Participants Stroke survivors (N=35; 22 men; mean age, 66.9±12.7y). Interventions Four counseling sessions over 7 weeks with a message of sit less and move more (intervention group) or calcium for bone health (attention-matched control group). Main Outcome Measures Measures included safety (adverse events, increases in pain, spasticity, or fatigue) and feasibility (adherence to trial protocol). Secondary measures included time spent sitting (including in prolonged bouts ≥30min)..